Navigation Links
Posit Science Co-Founder and Brain Plasticity Pioneer, Michael Merzenich, Speaks at Science Conference in the Netherlands
Date:12/10/2008

AMSTERDAM, Netherlands, Dec. 10 /PRNewswire/ -- Michael Merzenich, PhD, a leading research scientist at the University of California and the Chief Scientist of Posit Science Corporation, gave the plenary lecture today at the opening ceremony of a joint conference of the Netherlands Institute for Neuroscience and the Royal Netherlands Academy of Arts and Science in Amsterdam. His talk, entitled "Cortical Plasticity-Based Therapeutics," presented evidence that neuroplasticity-based training can be a new kind of therapeutic tool used to address a wide variety of conditions from healthy aging to mental illness to dementia to brain injury.

Dr. Merzenich's company, Posit Science, translates the latest breakthroughs in neuroscience into cognitive training software that improves lives. The company's technology has been validated in many randomized controlled trials, and researchers have reported in more than 30 peer-reviewed articles in science and medical journals on numerous benefits, including: more than a doubling of processing speed; gains in memory and other cognitive functions equivalent to more than 10 years; improvements in activities correlated to maintaining independence; lower risk of serious decline in health related quality of life; better driving abilities and lower crash risk.

The Brain Fitness Program Classic(TM) was introduced by Posit Science in 2006 to improve auditory processing and memory. InSight(TM) was introduced by the company this year to improve visual processing and memory. Both programs are available from the company's website www.positscience.com.

The three day conference commemorates the 200th anniversary of the Royal Netherlands Academy of Arts and Science. Dr Merzenich will moderate all panel discussions tomorrow.

Dr. Merzenich is Professor Emeritus at the University of California, San Francisco, where he maintains a research lab and is a member of the National Academy of Sciences and of the Institute of Medicine. His discoveries have led to numerous inventions and have helped to revolutionize how scientists think about the brain.

About Posit Science:

Posit Science is the leading provider of clinically validated brain fitness programs. The company works with more than 50 scientists from prestigious universities to design and test its computer-based programs. More than 30 published papers show that in randomized controlled trials the company's patented technologies significantly increase processing speed, improve memory and attention, and enhance the quality of everyday life. Posit Science has received grants from the National Institutes of Health and has received numerous awards and accolades. The company's products, scientists and science are currently featured in the PBS documentaries "The Brain Fitness Program" and "Brain Fitness 2: Sight and Sound." For more information, visit http://www.PositScience.com or call 1-866-599-6463.


'/>"/>
SOURCE Posit Science Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Positively Conscious: An Enlightened Look At Life
2. Long Term Care Sector Supports and Is Well-Positioned to Advance Health Care Reform, Bolster Economic Stimulus
3. 11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions
4. American Academy of Dermatology Issues Position Statement on Vitamin D
5. MannKind Reports Positive Results from Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
6. Largest study of fertility patients shows concerns about embryo disposition
7. Posit Science Featured in Canadian Documentary on the Brain
8. Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions
9. Opposition Continues to Grow to Blues Legislation
10. European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naive Adults With HIV-1
11. BET Networks Joins the International Call to Stop the Spread of HIV on World AIDS Day Monday, December 1 with a Special Episode of 106 & PARK Followed by BET News Exclusive ARE YOU POSITIVE?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
(Date:10/12/2017)... ... 2017 , ... Vohra Chief Medical Officer Dr. Shark Bird, ... nursing facility medical directors and other clinicians at various events in October. His ... many of these conferences we get to educate other physicians, facility nurses, corporate ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
Breaking Medicine Technology: